Business Wire

Pure Lithium and E3 Lithium Report Results From Phase 1 of the Lithium Metal Battery Joint Development Agreement

Share

Pure Lithium Corporation, a disruptive vertically integrated lithium metal battery technology company, is pleased to announce initial results from the battery cells manufactured under the Joint Development Agreement with E3 Lithium, using E3 Lithium’s brines and DLE technology and Pure Lithium’s innovative extraction and battery technology.

Several variations of E3’s lithium chloride concentrate were used to make lithium metal anodes at Pure Lithium’s Boston facility. The lithium from the E3 concentrated lithium chloride was electrodeposited as pure lithium metal onto a copper substrate, creating a complete, battery ready anode. These anodes were then assembled by Pure Lithium into batteries, and their electrochemical performance was evaluated in full cells. Notable results include:

  • Lithium Metal Purity: The various E3 brine streams all achieved a very high purity level, > 99.9% pure lithium metal as tested by ICP-OES analysis.
  • Cell Performance (Life Cycle): This tests for the number of charge and discharge cycles the battery achieves while retaining 80% of its capacity. All cells achieved over 500 cycles to date.
  • Charge and Discharge Rates: This tests for the duration of a charge and discharge. These tests were conducted at a 1C:1D ratio, one hour charge time and one hour discharge time.

The results of this study concluded that an easily producible version of E3’s lithium concentrate provided the most cost-effective feedstock for use in Pure Lithium’s batteries. It also demonstrated the robustness of Pure Lithium’s process, showing no performance differences between batteries made using lithium chloride from E3’s Leduc Brines, and those made from Pure Lithium’s standard sources. The two companies continue to collaborate on the development and planning of an integrated process that can deliver the highest purity lithium metal anodes at the lowest possible cost.

“I am delighted to reinvent the lithium supply chain with E3 Lithium. We not only produced pure lithium metal anodes from unconventional sources of lithium using a newly invented technology but also validated their performance by cycling them in over 100 batteries. Rigorous electrochemical testing of battery materials is imperative, and to get such great results consistently, using a technology that was specifically developed to be cost effective, is truly exciting,” said Emilie Bodoin, Founder, Chairman & CEO of Pure Lithium.

“These results confirm that E3’s lithium concentrate can produce battery-ready lithium metal anodes using Pure Lithium’s technology,” said Chris Doornbos, President and CEO of E3 Lithium. "The Pure Lithium team has worked very hard in making these batteries and confirming the performance of our lithium. We are very encouraged by the results, and I am excited by the prospect of developing a local lithium battery supply chain in collaboration with Pure Lithium.”

About Pure Lithium

Pure Lithium is a disruptive Boston-based lithium metal battery technology company led by inventor and lithium expert, CEO Emilie Bodoin, and world-renowned battery and metallurgical expert, MIT Emeritus Professor Donald R. Sadoway, as full-time CSO. The Company's novel Brine to Battery™ technology combines metal extraction and anode production, unlocking unconventional sources of lithium. The resulting pure lithium metal anode is the core component of our lithium metal vanadium oxide battery, a step-change improvement over today’s lithium-ion technology in cell performance, cost, and safety. Additionally, the battery is free of graphite, cobalt, nickel, and manganese. For more information, visit www.purelithium.io or email news@purelithium.io.

About E3 Lithium

E3 Lithium is a development company with a total of 16.2 million tonnes of lithium carbonate equivalent (LCE) Measured and Indicated 1 as well as 0.9 million tonnes LCE Inferred mineral resources2 in Alberta and 2.5 million tonnes LCE Inferred mineral resources3 in Saskatchewan. The Clearwater Pre-Feasibility Study outlined a 1.13 Mt LCE proven and probable mineral reserve with a pre-tax NPV8% of USD 5.2 Billion with a 29.2% IRR and an after-tax NPV8% of USD 3.7 Billion with a 24.6% IRR1. E3 Lithium’s goal is to produce high purity, battery grade lithium products to power the growing electrical revolution. With a significant lithium resource and innovative technology solutions, E3 Lithium has the potential to deliver lithium to market from one of the best jurisdictions in the world.

1: The Clearwater Project NI 43-101 Pre-Feasibility Study, effective June 20, 2024, is available on the E3 Lithium’s website (https://e3lithium.ca/our-assets/technical-reports/) and SEDAR+ (www.sedarplus.ca).

2: The mineral resource NI 43-101 Technical Report for the North Rocky Property, effective October 27, 2017, identified 0.9 Mt LCE (inferred) and is available on the E3 Lithium’s website (e3lithium.ca/technical-reports) and SEDAR+ (www.sedarplus.ca).

3: The mineral resource NI 43-101 Technical Report for the Estevan Lithium District, effective May 23, 2024, identified 2.5 Mt LCE (inferred) and is available on the E3 Lithium’s website (e3lithium.ca/technical-reports) and SEDAR+ (www.sedarplus.ca).

View source version on businesswire.com: https://www.businesswire.com/news/home/20250522582010/en/

Contacts

Ross Larsen
Head of Editorial, 33 Communications
Purelithium@thirtythreecomms.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeiGene Presents Pioneering Cancer Research at ASCO 2025 – Redefining Treatment Across Hematology and Solid Tumors22.5.2025 13:00:00 EEST | Press release

BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that will change its name to BeOne Medicines Ltd., today announced it will share 23 abstracts featuring new data across its hematology and solid tumor portfolio at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL, May 30 – June 3, 2025. With two abstracts selected for rapid oral presentation, these data reflect the Company’s vision to address cancer across multiple fronts and provide innovative medicines to as many patients as possible worldwide. “ASCO is a powerful platform for highlighting progress in cancer care, and we’re proud to contribute 23 accepted abstracts that reflect our mission to improve outcomes for more patients around the world,” said Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeiGene. “From long-term follow-up results for BRUKINSA in CLL to first-time clinical data for two promising breast cancer assets, our presentations this year spea

Quant Makes Money Smarter With Rollout of Industry-Wide Programmable Money22.5.2025 11:07:00 EEST | Press release

Quant, a global leader in fintech and innovation, today announces the rollout of Quant Flow, an industry-first programmable money and banking infrastructure now available via a white-label solution to banks, institutions and corporates across Europe, the Middle East, and APAC. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250522277808/en/ Gilbert Verdain, CEO of Quant Quant Flow was developed in response to the growing demand for smarter forms of commercial bank money and the need to modernise financial infrastructure, driven by rising regulatory pressure and competition from stablecoins, central bank digital currencies (CBDCs), neobanks and fintechs. Quant Flow delivers automation and intelligence directly into money at the account level. For banks, this means they can respond to market demand, address regulation, innovate with new forms of money and defend profitability – all without the need for costly system overhauls.

Manchester City Puts Smart Water Tech in Play on the Pitch22.5.2025 11:00:00 EEST | Press release

Manchester City Football Club is using data and analytics for more than performance on the pitch. A champion of water sustainability, the Club is taking its commitment to the next level – introducing digital solutions from its official water technology partner, Xylem (NYSE: XYL), to help capture and reuse rainwater more efficiently. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250522922860/en/ Manchester City Football Club is teaming up with Xylem to bring smart water management to City Football Academy. With the help of Xylem Vue, the Club is capturing and reusing rainwater more efficiently through data and analytics. At City Football Academy, Xylem Vue – a digital water platform – uses connected sensors and smart meters to deliver live insights into how water moves across the training facility. Showing exactly when and where water is being used or lost across the 16.5-pitch campus, the system helps the Club make smarter

Manhattan Associates Unveils Agentic AI Innovation at Momentum 202522.5.2025 10:00:00 EEST | Press release

Kicking off Momentum 2025, Manhattan Associates Inc. (NASDAQ: MANH) today announced sweeping Agentic AI support within Manhattan Active® solutions that includes intelligent, autonomous digital agents to revolutionise supply chain commerce execution, optimisation, and user experiences. These out-of-the-box AI agents, powered by large language models (LLMs) and Manhattan’s cloud-native, all-microservice API architecture, will autonomously perform tasks, adapt to changing conditions, and dynamically orchestrate workflows. This breakthrough marks a generational leap from traditional chatbots and static workflow configurations to dynamic, intelligent, and situationally aware orchestration across the entire supply chain and commerce lifecycle. Among the first groundbreaking AI agents announced are the Intelligent Store Manager, Labor Optimizer Agent, Wave Inventory Research Agent, Contextual Data Assistant, and Virtual Configuration Consultant. These digital agents allow users to interact wi

Empowering Local Industry: SFI Health ™ EMEA Commits to South African Packing Operations22.5.2025 09:30:00 EEST | Press release

SFI Health™ EMEA, the regional entity of SFI Health™, a global leader in natural healthcare, is proud to announce that the packing of its branded products in South Africa will be now fully managed locally leveraging local talent and facilities. The company is known for its clinically researched products in microbiome, cognition, and well-being. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250521282786/en/ This initiative enhances SFI Health South Africa’s ability to offer greater flexibility in pack sizes, ensuring a product portfolio that aligns more closely with the needs of South African consumers. By taking this step, the company aims to make its scientifically supported health solutions more accessible, without compromising on quality or efficacy. Simultaneously, this initiative will have a positive ripple effect on the local economy: all packaging materials will be sourced from South African suppliers, and the produc

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye